Skip to main content

Table 1 Baseline Characteristics

From: Usefulness of ECG to differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome

 

ApHCM (n = 41)

NSTEACS (n = 72)

P-value

Men

27 (65.9)

26 (36.1)

0.002

Age (years)

68.29 ± 11.12

70.27 ± 10.55

0.384

Smoking

12 (29.3)

22 (30.6)

0.886

Drinking

5 (12.2)

7 (9.7)

0.682

Hypertension

28 (68.3)

54 (75)

0.442

Diabetes mellitus

5 (12.2)

21 (29.2)

0.039

LAD (mm)

42.09 ± 4.54

39.38 ± 4.71

0.004

LVEDd (mm)

47.82 ± 3.93

47.40 ± 5.58

0.320

LVEDs (mm)

29.97 ± 3.01

32.08 ± 5.85

0.158

IVS (mm)

11.65 ± 2.42

9.61 ± 1.21

<  0.001

LVPW (mm)

9.82 ± 1.04

9.25 ± 0.91

0.001

LVEF (%)

65.65 ± 4.89

59.13 ± 9.32

<  0.001

E/A

0.97 ± 0.59

0.84 ± 0.37

0.853

E/Em

10.12 ± 5.92

10.10 ± 4.97

0.795

  1. Abbreviation: A Late diastolic inflow velocity, ApHCM Apical hypertrophic cardiomyopathy, E Early diastolic inflow velocity, Em Early diastolic annular tissue velocity, IVS Interventricular septal, LAD Left atrial diameter, LVEDd Left ventricular end diastolic diameter, LVEDs Left ventricular end systolic diameter, LVEF LEFT ventricular ejection fraction, LVPW Left ventricular posterior wall, NSTEACS Non-ST elevation acute coronary syndrome
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us